# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001108205-26-000068
Filing Date
2026-06-05
Accepted
2026-06-05 09:06:26
Documents
4
Period of Report
2026-06-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | curis_2026specialmeetingrs.htm | DEF 14A | 275708
2 |  | curisinc_vxprxyxs39460x269.jpg | GRAPHIC | 463986
3 |  | curisinc_vxprxyxs39460x269a.jpg | GRAPHIC | 288093
4 |  | image_0.jpg | GRAPHIC | 13933
| Complete submission text file | 0001108205-26-000068.txt |  | 1331360

Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30347 | Film No.: 261067034
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)